Sysmex announces that its Sysmex XE-2100D Automated Hematology Analyzer has been cleared by the FDA for blood processing center Quality Control release testing of post-processed red blood cell and platelet components collected using a variety of anticoagulants.
Read MoreAbbott announced it has received approval from the FDA for its ABBOTT PRISM HIV O Plus test, the first fully automated blood screening test for HIV-1/HIV-2.
Read MoreAlmac and Lilly UK have entered into a partnership to develop a companion diagnostic for ALIMTA, with cisplatin, as a combination therapy for non-squamous non-small cell lung cancer.
Read MoreDionex Corp has entered into an Asset Purchase Agreement with ESA Biosciences, a wholly owned subsidiary of Magellan Biosciences Inc, to purchase ESA Biosciences HPLC related products, HPLC clinical assays, laboratory services and assets.
Read MoreSequenom Inc announces that the company’s first laboratory developed test, the SensiGene Cystic Fibrosis (CF) Carrier Screening test, has been launched. This test is available exclusively through the Sequenom Center for Molecular Medicine, a next-generation CLIA molecular diagnostic laboratory and a wholly-owned subsidiary of Sequenom.
Read More